Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ritter

Showing results (751-760 of 756) with videos related to

Pageof 76
Sort By:
You have reached the last page of results.This site can display upto 756 results.
Practical Radiation Oncology|September 5, 2024
Centralized Quality Assurance of Stereotactic Body Radiation Therapy for the Veterans Affairs Cooperative Studies Program Study Number 2005: A Phase 3 Randomized Trial of Lung Cancer Surgery or Stereotactic Radiotherapy for Operable Early-Stage Non-Small Cell Lung Cancer (VALOR)Timothy A Ritter, Robert D Timmerman, Hena I Hanfi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2016
Patient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancerSkyler Bryce Johnson, Pamela R Soulos, Timothy D Shafman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2026
Chemoradiation ± Atezolizumab in Limited-Stage Small Cell Lung Cancer: Results of NRG Oncology/Alliance LU005Kristin A Higgins, Chen Hu, Helen J Ross, et al.
Adsorption : Journal of the International Adsorption Society|April 9, 2019
A reference high-pressure CO<sub>2</sub> adsorption isotherm for ammonium ZSM-5 zeolite: results of an interlaboratory studyH G T Nguyen, L Espinal, R D van Zee, et al.
Neuro-Oncology|June 12, 2016
EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activationEskil Eskilsson, Gro V Rosland, Krishna M Talasila, et al.
BMJ Global Health|October 23, 2024
Oral varespladib for the treatment of snakebite envenoming in India and the USA (BRAVO): a phase II randomised clinical trialCharles J Gerardo, Rebecca W Carter, Surendra Kumar, et al.
Pageof 76

Showing results (751-760 of 756) with videos related to

Sort By:
Pageof 76
You have reached the last page of results.This site can display upto 756 results.
Practical Radiation Oncology|September 5, 2024
Centralized Quality Assurance of Stereotactic Body Radiation Therapy for the Veterans Affairs Cooperative Studies Program Study Number 2005: A Phase 3 Randomized Trial of Lung Cancer Surgery or Stereotactic Radiotherapy for Operable Early-Stage Non-Small Cell Lung Cancer (VALOR)Timothy A Ritter, Robert D Timmerman, Hena I Hanfi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2016
Patient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancerSkyler Bryce Johnson, Pamela R Soulos, Timothy D Shafman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2026
Chemoradiation ± Atezolizumab in Limited-Stage Small Cell Lung Cancer: Results of NRG Oncology/Alliance LU005Kristin A Higgins, Chen Hu, Helen J Ross, et al.
Adsorption : Journal of the International Adsorption Society|April 9, 2019
A reference high-pressure CO<sub>2</sub> adsorption isotherm for ammonium ZSM-5 zeolite: results of an interlaboratory studyH G T Nguyen, L Espinal, R D van Zee, et al.
Neuro-Oncology|June 12, 2016
EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activationEskil Eskilsson, Gro V Rosland, Krishna M Talasila, et al.
BMJ Global Health|October 23, 2024
Oral varespladib for the treatment of snakebite envenoming in India and the USA (BRAVO): a phase II randomised clinical trialCharles J Gerardo, Rebecca W Carter, Surendra Kumar, et al.
Pageof 76